Simplify Logo
Biolinq

Biolinq

Biowearable biosensor platform for metabolic health

Manufacturing Supervisor - Pilot Line

Full-Time
$85k - $101k/yr

+ Annual performance bonus + Incentive compensation

Senior
Bachelor's
San Diego, CA, USA
In Person

About the job

Requirements
  • A B.S. degree or higher in Operations Management, Engineering, Life Sciences, or a related field is preferred; equivalent hands-on equipment experience will be considered.
  • At least five years of experience in medical device, pharmaceutical, or other regulated manufacturing environments is preferred.
  • Candidates with fewer years in a formal supervisory title may qualify with process or technical leadership, informal team leadership, or subject matter expertise, provided they can demonstrate the ability to establish a new pilot line from the ground up.
  • Direct experience supporting new product introduction, process validation using Installation Qualification, Operational Qualification, and Performance Qualification, or pilot-to-production scale-up is strongly preferred.
  • Working knowledge of FDA Quality System Regulation under 21 CFR Part 820 and ISO 13485 requirements is required.
  • Strong troubleshooting and hands-on problem-solving skills in an equipment- and process-driven environment are required.
  • Working knowledge of lean manufacturing and continuous improvement methods, including 5S and root cause analysis, is required.
  • The role requires compliance with cleanroom gowning and entry protocols, the ability to stand and walk for extended periods, frequent bending, reaching, and fine motor movement, and the ability to lift and carry up to 25 pounds.
  • The employee must be able to work flexible hours, including off-shift or weekend coverage during line build-out, validation, and scale-up phases.
  • The employee may occasionally need to lift or move up to 50 pounds.
Responsibilities
  • Partner with Process and Manufacturing Engineering to install, set up, and commission pilot-line equipment and workstations.
  • Support Installation Qualification, Operational Qualification, and Performance Qualification activities for new equipment and processes.
  • Translate process development and engineering documentation into standard operating procedures and work instructions for production.
  • Identify and troubleshoot early-stage process, equipment, and workflow issues with Engineering and Quality.
  • Contribute to line layout, material flow, and staffing plans for pilot-scale output and future scale-up.
  • Supervise day-to-day pilot-line operations, including staffing, scheduling, and shift coverage.
  • Directly supervise, coach, and develop manufacturing associates and line technicians; conduct performance reviews and support hiring and onboarding.
  • Monitor production schedules, throughput, and yield; escalate and resolve issues that threaten output, quality, or timelines.
  • Ensure work follows approved standard operating procedures, batch records, device history records, and current Good Manufacturing Practice requirements.
  • Lead daily tier meetings, shift handoffs, and cross-functional communication.
  • Manage inventory control and transactions in the enterprise resource planning system.
  • Cover the commercial line when needed.
  • Ensure manufacturing activities comply with FDA Quality System Regulation, ISO 13485, and applicable medical device regulations.
  • Support investigations, nonconformance reports, corrective and preventive actions, and deviation handling for the pilot line.
  • Champion safety practices and ensure adherence to environmental, health, and safety requirements in a clean, organized, audit-ready environment.
  • Participate in internal and external audits and regulatory inspections as a subject matter expert on pilot-line operations.
  • Identify and lead continuous-improvement initiatives, including lean manufacturing and 5S, to improve safety, quality, throughput, and cost.
  • Partner with Engineering and Operations leadership to plan the transition from pilot-scale to higher-volume production, including equipment, staffing, and process changes.
  • Help build training programs, documentation, and team structures for future product lines beyond the initial continuous glucose monitoring sensor.
  • Perform other duties required to support team objectives and department goals.
Desired Qualifications
  • Experience with FDA Quality System Regulation and ISO 13485 audits is a plus.
  • Strong coaching and people-leadership instincts, including scheduling and performance management across a growing, multi-shift team.
  • Ability to build and scale new operations while balancing speed with medical-device rigor.
  • Ability to work collaboratively across Engineering, Quality, Supply Chain, and Operations Leadership.
  • Experience with equipment, microscopes, magnification tools, or precision instrumentation in a cleanroom or controlled laboratory environment.

About the company

Biolinq develops a biowearable platform with tiny under-skin sensors that monitor metabolic health, including glucose, by sensing multiple analytes. The sensors continuously collect data below the skin and transmit to an app or clinician for insights and personalized medicine. It differentiates by being a small, under-skin, multi-analyte system backed by university bioengineering research, not external wearables or single markers. Its goal is to gain regulatory approval and bring scalable, continuous metabolic health monitoring to patients.

Company Size

51-200

Company Stage

Series C

Total Funding

$316.4M

Headquarters

San Diego, California

Founded

2012

Get referred to Biolinq

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Biolinq closed a $100 million Series C on April 22, 2025, funding commercialization.
  • ADA 2026 data strengthened Shine after its 2025 FDA clearance, supporting physician credibility.
  • The new FDA category gives Biolinq a first-mover story against later needle-free entrants.

What critics are saying

  • Dexcom Stelo and Abbott Lingo already own OTC glucose monitoring in 2026.
  • Biolinq still lacks a predetermined change control plan, slowing future sensor upgrades.
  • If FDA or payers reject premium pricing, Biolinq stays a niche hardware company.

What makes Biolinq unique

  • Biolinq Shine won FDA De Novo on September 23, 2025, defining a new category.
  • Its autonomous, needle-free glucose sensor uses intradermal microsensors, not fingersticks or deep filaments.
  • Biolinq targets multi-analyte metabolic sensing, including glucose, lactate, and ketones, beyond single-metric CGMs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Holidays

Paid Vacation

PTO

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-2%
Yahoo Finance
Feb 2nd, 2026
Biolinq CEO predicts smart patches will dominate wearables after $100M Series C

Smart patches could become the next major wearables category after smartwatches and rings, according to Richard Yang, CEO of diabetes biosensor company Biolinq. Unlike watches that track digital biomarkers, smart patches monitor biomarkers linked to the body's internal chemistry. Biolinq raised $100 million in a Series C round in April 2025, bringing total funding to around $300 million. The company secured FDA de novo classification for its Shine biosensor in September 2025, making it the first needle-free continuous glucose monitoring device in the US market. The device uses microneedle arrays that only penetrate the skin's top layer. Yang says the consumer health domain is "hungry" for such technology. Biolinq plans to expand beyond diabetes monitoring, with future applications potentially tracking multiple health metrics simultaneously through semiconductor-based biosensor chips.

Live Forever Club CIC
May 5th, 2025
Biolinq raises $100M for glucose monitor

Biolinq, a California-based health tech company, has secured $100 million in Series C funding to advance its needle-free glucose monitor for Type 2 diabetes. The coin-sized patch uses electrochemical sensors to track glucose, lactate, and ketones without penetrating deeply into tissue. It also monitors sleep and activity, providing real-time feedback. The funding, led by Alpha Wave Ventures, will support development, U.S. regulatory submissions, and commercial rollout.

Venture Capital Investor
Apr 29th, 2025
Biolinq Secures $100 Million Series C

Biolinq, a maker of a biowearable glucose sensor platform, has closed a $100 million Series C financing round led by Alpha Wave Ventures, with participation from existing investors including RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical, and Features Capital.

FinSMEs
Apr 23rd, 2025
Biolinq Closes $100M Series C Financing

Biolinq, a San Diego, CA-based healthcare technology company providing precision multi-analyte biosensors, raised $100M in Series C funding.

Medical Device Network
Apr 23rd, 2025
Biolinq raises $100m to support US launch of intradermal glucose sensor

Biolinq has secured $100m in a Series C funding round to support the regulatory approval process in the US as it aims to launch its autonomous intradermal glucose sensor to the market.